Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
---|---|---|---|---|---|---|
A Phase 3, Open-Label, Single-Arm Trial Evaluating the Safety, Tolerability, and Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine in Children With Sickle Cell Disease Previously Immunized With 23 Valent pneumococcal polysacchride Vaccine. | Pfizer | Completed | 13-valent Pneumoccocal Conjugate Vaccine | 3 | B1851013 | King Faisal Specialist Hospital and Research Center (Riyadh) |